In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Japan Tobacco licenses Gilead's HIV drugs in Japan
Sangamo signs research agreement with Japan Tobacco
Meristem and Japan Tobacco license agreement
Roche and Japan Tobacco enter agreement on a novel approach to treat high lipid levels in the blood
Gilead and Japan Tobacco Sign Licensing Agreement for Novel HIV Integrase Inhibitor
Athenix obtains commercial license from Japan Tobacco
Chiron grants HCV license to Japan Tobacco
Cell Genesys Receives US$2.5 Million Payment
Cell Genesys to receive $16.8 Million in connection with previously terminated agreement